This session will explore ways of quickening the pulse of the AIDS movement at this critical time when the AIDS response is under threat and activism is being marginalized.
HIV/AIDSSee more about HIV/AIDS
- view as grid
- view as list
AIDS 2012: Press Conference: Labs for Life: PEPFAR, CDC and BD Announce New Labs Strengthening Initiative
BD (Becton, Dickinson and Company) and the U.S. Presidentâ€™s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Servicesâ€™ Centers for Disease Control and Prevention (CDC) will unveil the results of a five-year collaboration that improved overall laboratory systems and services in African countries severely affected by HIV/AIDS and tuberculosis (TB).
AIDS 2012: The Future of HIV Prevention, Health and Human Rights in Gay, other MSM and Transgender Communities: Towards More Effective Approaches with ICTs in a Web 2.0 World
This session critically explores why existing public health approaches to mobilizing communities for HIV prevention may be ineffective in achieving improved health and human rights.
Directed at clinicians, scientists and programme managers interested in HIV in women, this symposia session will address key topics in the continuum of HIV infection in women throughout the lifespan (excluding fertility and pregnancy which are addressed in other sessions).
The use of contraception is a powerful public health intervention which reduces maternal mortality, improves infant and child outcomes, impacts on PMTCT and empowers women.
This session will focus on the major shift in the architecture of global development assistance since Gleneagles, with particular reference to the current crisis around the Global Fund and declining interest in some rich countries in the epidemic.
From Promise to Programmes: Treatment as Prevention
Taking into account the recent organizational reforms, this session will discuss the strategic direction and future hopes of the Global Fund from the perspective of the recently appointed General Manager, implementing countries, members of civil society, and the donor community.
Official Press Conference
Can Early Treatment of HIV infection give grounds for interruption of antiretroviral treatments?